Background and objectives: MicroRNAs are small non-coding RNAs involved in pathogenesis and progression of human malignancies. ) is down-regulated in many human cancers where it would serve as a tumour suppressor.
| INTRODUCTION
Osteosarcoma, although rare, is the most common primary bone tumour in children and young adults 1 and is characterized by osteoid production and osteoblastic differentiation. 2 In recent decades, the incidence of osteosarcoma has increased nearly 1.4% each year, 3 and while surgical excision is the primary treatment, many osteosarcoma patients have a poor clinical outcome. 4, 5 Although the 5-year survival rate for patients with non-metastatic osteosarcoma has increased >50% with the use of neoadjuvant chemotherapy, patients with recurrent or metastatic osteosarcoma continue to have a poor prognosis. 6, 7 Furthermore, only a small number of established diagnostic and prognostic osteosarcoma biomarkers are available. Therefore, there is an urgent need to identify new biomarkers that can be used to improve the treatment and prognosis of osteosarcoma patients, and especially highrisk patients.
MicroRNAs (miRNAs) are endogenous small non-coding RNAs, which are 22-24 nucleotides in length and play crucial roles in posttranscriptional regulation. 8 MiRNAs bind to the 3′-untranslated region (3′-UTR) of their target mRNA molecules and thereby suppress their translation or stimulate their degradation. 9, 10 Downregulation of a miRNA usually results in overexpression of its target gene. Previous studies have shown that 98 miRNAs are located at different genomic regions involved in human tumorigenesis, suggesting that miRNAs are involved in the development and pathogenesis of malignancies, and could possibly serve as diagnostic or prognostic tumour biomarkers. 11 Furthermore, miRNAs play critical roles in a variety of other cellular processes, including tumour growth, 12 cell apoptosis 13 and tumour cell metastasis, 14 and can act as either oncogenes or anti-oncogenes. 15 Additionally, the expression profiles of different miRNAs in plasma, serum and tumour samples have been used to accurately classify human cancers, suggesting that miRNAs could possibly serve as biomarkers for diagnosing human cancers and developing a prognosis for cancer patients.
16,17
When miRNA-491-5p was first identified in 2005, 18 its expression was shown to be down-regulated in certain malignant tumours. [19] [20] [21] [22] Other studies have reported that miR-491-5p overexpression is associated with inhibited cell growth and promotion of apoptosis in colorectal, 19 ovarian 22 and breast carcinomas. 21 A recent study that employed microRNA microarray methodologies found that miRNA-491-5p expression was significantly decreased in human osteosarcoma tissue. 23 However, the actual mechanism by which microRNA-491-5p affects the behaviour of osteosarcoma cells remains obscure.
We performed this study to define the role of miR-491-5p in human osteosarcoma tissue and investigate the effects of miR-491-5p
overexpression on human osteosarcoma cell proliferation, metastasis and apoptosis. As literature reports have identified forkhead-box P4
(FOXP4) as a potential target gene for miR-491-5p, we studied how miR-491-5p affects FOXP4 gene expression. 24 Each sample of carcinoma and pericarcinomatous tissue was examined by a trained pathologist ( Table 2 ).
| METHODS

| Tissue collection
All patients included in the study provided a signed informed consent document, allowing for the use of their clinical specimens in this research. The study protocol was approved by the Research Ethics
Committee of the First Affiliated Hospital of Guangzhou Medical University, China.
| Cell lines and culture conditions
Human osteoblast cell line hFOB (OB3) was purchased from the penicillin (100 IU/mL) and streptomycin (100 IU/mL). All cells were cultured and maintained in a humidified incubator set at 37°C and containing an atmosphere of 5% CO 2 .
| Quantitative real-time polymerase chain reaction (qRT-PCR) analysis
Total RNA was extracted from tumour tissues and cultured cells using 
| Protein extraction and Western blot
Total proteins from tissues and cells were extracted on ice for 30 minutes using SDS lysis buffer (Beyotime, Nantong, China), and the total amounts of extracted soluble protein were determined using a BCA 
| Plasmid construction
The full-length FOXP4 3′-untranslated region (3′-UTR) was cloned into a psi-CHECK2 vector (Promega) and designated as FOXP4-3′-UTR-WT. A QuikChange Site-Directed Mutagenesis Kit (Stratagene, San Diego, CA, USA) was used to construct a mutant 3′-UTR of FOXP4. The predicted target sites (UCCCCACC) were mutated to AGGGCCU. All plasmids were confirmed by DNA sequencing.
| Cell transfection
The miR-491-5p mimics and scrambled sequences (NCs)
were obtained from Guangzhou Ribobio, China. 
| Luciferase assay
For the luciferase reporter assay, aliquots of cells (100 μL) were cultured in 24-well plates and then co-transfected with 100 ng of FOXP4-3′-UTR-WT or -MUT psi-CHECK2 vectors plus 50 nM miR-491-5p mimics or scrambled sequences using Lipofectamine 2000 reagent. After 48 hours, the cells were harvested and lysed.
Luciferase activity was detected using the Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer's instructions.
Firefly luciferase activity was used as an internal reference standard.
| Cell viability assay
The proliferative capabilities of cells which received different treat- 
| 5-ethynyl-2-deoxyuridine (EdU) assay
SAOS-2 and MG63 cells were seeded into 96-well plates and transfected with miR-491-5p mimics or FOXP4-siRNA. At 48 h after transfection, 5-ethynyl-2′-deoxyuridine (EdU) (100 μm) (Cell Light EdU DNA imaging Kit; Guangzhou RiboBio, China) was added to each well, and the cells were cultured for an additional 2 hours; after which, they were stained as previously described. 25 EdU-positive cells were identified in parallel by staining with Apollo ® 643 azide and flow cytometric analysis.
| Cell apoptosis assay
Apoptosis was assessed as previously described. identified cells that were in the early and later stages of apoptosis, respectively.
The Hoechst 33342 nuclear staining method was also used to detect apoptotic cells. Briefly, cells were seeded into six-well plates and cultured with Hoechst 33342 blue fluorescent nuclear dye (Sigma) for 30 minutes; after which, their nuclear morphology was examined with a fluorescence microscope equipped to detect Hoechst 33342 staining at 365 nm.
| Cell migration and invasion assays
Cell migration and invasion assays were performed as previously described. 
| Electrophonic mobility shift assay (EMSA)
EMSAs were performed using a second-generation DIG Gel Shit Kit (Roche Diagnostics, Mannheim, Germany). Briefly, doublestranded oligonucleotide probes containing the FOXP4 binding sites were obtained from Sangon Biotech (Shanghai, China). The nuclear proteins in SAOS-2 and MG63 cells were extracted using a CelLytic™ NuCLEAR™ Extraction Kit (Sigma) according to the manufacturer's instructions. The EMSA assays were performed as previously described. 27 The oligonucleotide was electro-blotted onto a positively charged nylon membrane (Roche Diagnostics, Indianapolis, IN, USA) and immunodetected using anti-digoxigenin-AP (Roche Diagnostics).
| Statistical analysis
The data were analysed using PASW Statistics for Windows, Version 
| RESULTS
| Osteosarcoma tissue and cell lines had reduced levels of miR-491-5p expression
The levels of miR-491-5p expression as determined by qRT-PCR were lower in samples of tumour tissue when compared with their levels in matched samples of normal tissue (n=43) ( Figure 1A ) and were down-regulated in osteosarcoma cells ( Figure 1B) . These results suggested that miR-491-5p might play a role in human osteosarcoma and formed the basis for our further investigations using SAOS-2 and MG-63 cells.
| miR-491-5p expression and clinicopathological features in osteosarcoma patients
Clinical pathology findings in the 43 osteosarcoma patients included in our study are shown in 
| Overexpression of miR-491-5p suppressed osteosarcoma cell migration and invasion
The relationship between miR-491-5p expression levels and the migration/invasion capabilities of osteosarcoma cells was examined in vitro using the transwell assay. The results showed that the migration and invasion capabilities of SAOS-2 and MG-63 cells were inhibited following transfection with miR-491-5p mimics (Figure 3 ).
| Overexpression of miR-491-5p induced apoptosis in osteosarcoma cells
The effect of miR-491-5p on cell apoptosis was first examined using 
| Forkhead-box P4 (FOXP4) is a target of miR-491-5p
The levels of FOXP4 protein expression in human osteosarcoma tissue and osteosarcoma cell lines were detected in Western blot studies which showed that FOXP4 expression was increased in both the tissues samples ( Figure 5A ) and cell lines ( Figure 5B) . Furthermore, the levels of FOXP4 mRNA expression in SAOS-2 and MG63 cells transfected with miR-491-5p mimics were detected using qRT-PCR ( Figure 5C,D) . The results showed that FOXP4 mRNA expression in SAOS-2 and MG63 cells was significantly decreased after the cells had been transfected with miR-491-5p mimics ( Figures 4D and 5C ).
Moreover, Western blot results showed that overexpression of miR-491-5p suppressed FOXP4 protein expression ( Figure 5E ). When taken together, these results indicate that miR-491-5p suppresses FOXP4 expression at mRNA and protein levels.
To determine whether FOXP4 a target gene for miR-491-5p, we used the miRNA target predication databases (TargetScan: www.
targetscan.org and miRDB: www.mirdb.org) to perform a computational analysis which showed that MiR-491-5p has one predicted target site in the human FOXP4 3′-UTR ( Figure 5F ). Next, a dualluciferase reporter system assay was performed to confirm that FOXP4 is a direct target of miR-491-5p. The assay results showed that miR-491 mimics suppressed the reporter's luciferase activity and that the luciferase expression displayed by the mutant 3′-UTR of FOXP4 was no longer regulated by miR-491-5p ( Figure 5G ). These results confirmed that the selected site in the 3′-UTR of FOXP4 was a miR-491-5p regulation site and that FOXP4 is a target gene for miR-491-5p.
| miR-491-5p suppressed FOXP4 activity in SAOS-2 and MG63 cells
FOXP4 is a transcription factor involved in cell-specific and tissue-specific gene regulation. Therefore, we examined whether Figure 6 ).
| Knockdown of FOXP4 suppressed osteosarcoma cell proliferation
We next examined the effects of FOXP4 knockdown resulting from RNA interference following transfection with siRNA ( Figure 7A,B) . The results showed that the levels of FOXP4 mRNA and protein expression were significantly decreased in SAOS-2 and MG63 cells transfected with FOXP4-siRNA ( Figure 7A,B,E) . Furthermore, the results of both CCK-8 and EdU assays showed that knockdown of FOXP4 inhibited the proliferation of SASO-2 and MG63 cells ( Figure 7C ,E).
| Knockdown of FOXP4 inhibited osteosarcoma cell migration and invasion
Transwell assays showed that SAOS-2 and MG-63 cells transfected with FOXP4-siRNA had reduced migration and invasion capabilities (Figure 8 ).
| Knockdown of FOXP4 promoted osteosarcoma cell apoptosis
The Annexin V-FITC/PI staining method used for performing apoptosis assays showed that knockdown of FOXP4 promoted apoptosis in 
| DISCUSSION
Several recently published studies have supported a role for microRNAs (miRNAs) in regulating fundamental normal and reactive cellular processes. 28, 29 Moreover, an increasing number of studies support a role for miRNA in the origination and progression of human cancers. [12] [13] [14] Dysregulation of miRNA activity may result in progressive and uncontrolled tumour growth. 47 In this study, we found significantly increased levels of FOXP4 gene and protein expression in osteosarcoma tissue and cell lines.
Knockdown of FOXP4 by RNA interference suppressed the proliferation and migration of osteosarcoma cells and was associated with increased levels of apoptosis in those cells. When taken together, these findings support the hypothesis that down-regulation of miR-491-5p promotes human osteosarcoma cell proliferation via a FOXP4-mediated signalling pathway.
| CONCLUSION
In conclusion, these in vitro studies showed that up-regulation of miR-491-5p suppressed human osteosarcoma cell proliferation and increased the levels of apoptosis in human osteosarcoma cells by as a potential clinical diagnostic or predictive biomarker for human osteosarcoma.
